82 related articles for article (PubMed ID: 22179005)
41. Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status.
Heide J; Zhang F; Bigos KL; Mann SA; Carr VJ; Shannon Weickert C; Green MJ; Weinberger DR; Vandenberg JI
Am J Psychiatry; 2016 Jan; 173(1):53-9. PubMed ID: 26481172
[TBL] [Abstract][Full Text] [Related]
42. Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity.
Yunomae K; Ichisaki S; Matsuo J; Nagayama S; Fukuzaki K; Nagata R; Kito G
J Appl Toxicol; 2007; 27(1):78-85. PubMed ID: 17146843
[TBL] [Abstract][Full Text] [Related]
43. Targeting ion channels in leukemias: a new challenge for treatment.
Arcangeli A; Pillozzi S; Becchetti A
Curr Med Chem; 2012; 19(5):683-96. PubMed ID: 22204341
[TBL] [Abstract][Full Text] [Related]
44. Regulation of Kv11.1 Isoform Expression by Polyadenylate Binding Protein Nuclear 1.
Stump MR; Nguyen RT; Drgastin RH; Search D; Gong Q; Zhou Z
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467093
[TBL] [Abstract][Full Text] [Related]
45. Correction to "Long QT2 Mutation on the Kv11.1 Ion Channel Inhibits Current Activity by Ablating a Protein Kinase Cα Consensus Site".
Mol Pharmacol; 2019 Sep; 96(3):377. PubMed ID: 31371519
[No Abstract] [Full Text] [Related]
46. Potassium Ion Channels in Malignant Central Nervous System Cancers.
Boyle Y; Johns TG; Fletcher EV
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230692
[TBL] [Abstract][Full Text] [Related]
47. Potassium Channels as a Target for Cancer Therapy: Current Perspectives.
Zúñiga L; Cayo A; González W; Vilos C; Zúñiga R
Onco Targets Ther; 2022; 15():783-797. PubMed ID: 35899081
[TBL] [Abstract][Full Text] [Related]
48. The Effectiveness of Isoplumbagin and Plumbagin in Regulating Amplitude, Gating Kinetics, and Voltage-Dependent Hysteresis of
Chen L; Cho HY; Chuang TH; Ke TL; Wu SN
Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453530
[TBL] [Abstract][Full Text] [Related]
49. Antibodies Targeting K
Hernandez-Resendiz I; Hartung F; Pardo LA
Bioelectricity; 2019 Sep; 1(3):180-187. PubMed ID: 34471820
[TBL] [Abstract][Full Text] [Related]
50. Effects of curcumin complexes on MDA‑MB‑231 breast cancer cell proliferation.
Mohammed F; Rashid-Doubell F; Taha S; Cassidy S; Fredericks S
Int J Oncol; 2020 Aug; 57(2):445-455. PubMed ID: 32626932
[TBL] [Abstract][Full Text] [Related]
51. Characterization of Convergent Suppression by UCL-2077 (3-(Triphenylmethylaminomethyl)pyridine), Known to Inhibit Slow Afterhyperpolarization, of
Hsu HT; Lo YC; Wu SN
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093314
[TBL] [Abstract][Full Text] [Related]
52. Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells
Zhu G; Shen Q; Jiang H; Ji O; Zhu L; Zhang L
Pharm Biol; 2020 Dec; 58(1):25-34. PubMed ID: 31854220
[No Abstract] [Full Text] [Related]
53. A Membrane Potential- and Calpain-Dependent Reversal of Caspase-1 Inhibition Regulates Canonical NLRP3 Inflammasome.
Zhang Y; Rong H; Zhang FX; Wu K; Mu L; Meng J; Xiao B; Zamponi GW; Shi Y
Cell Rep; 2018 Aug; 24(9):2356-2369.e5. PubMed ID: 30157429
[TBL] [Abstract][Full Text] [Related]
54. Curcumin Acts as a Positive Allosteric Modulator of
El Nebrisi EG; Bagdas D; Toma W; Al Samri H; Brodzik A; Alkhlaif Y; Yang KS; Howarth FC; Damaj IM; Oz M
J Pharmacol Exp Ther; 2018 Apr; 365(1):190-200. PubMed ID: 29339457
[TBL] [Abstract][Full Text] [Related]
55. Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.
Chernet B; Levin M
J Clin Exp Oncol; 2013; Suppl 1():. PubMed ID: 25525610
[TBL] [Abstract][Full Text] [Related]
56. Curcumin protects against ischemic spinal cord injury: The pathway effect.
Zhang J; Wei H; Lin M; Chen C; Wang C; Liu M
Neural Regen Res; 2013 Dec; 8(36):3391-400. PubMed ID: 25206661
[TBL] [Abstract][Full Text] [Related]
57. Effects of curcumin on ion channels and transporters.
Zhang X; Chen Q; Wang Y; Peng W; Cai H
Front Physiol; 2014; 5():94. PubMed ID: 24653706
[TBL] [Abstract][Full Text] [Related]
58. Ion channels in cancer: future perspectives and clinical potential.
Lang F; Stournaras C
Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130108. PubMed ID: 24493756
[TBL] [Abstract][Full Text] [Related]
59. Altered expression of two-pore domain potassium (K2P) channels in cancer.
Williams S; Bateman A; O'Kelly I
PLoS One; 2013; 8(10):e74589. PubMed ID: 24116006
[TBL] [Abstract][Full Text] [Related]
60. Curcumin blocks Kv11.1 (erg) potassium current and slows proliferation in the infant acute monocytic leukemia cell line THP-1.
Banderali U; Belke D; Singh A; Jayanthan A; Giles WR; Narendran A
Cell Physiol Biochem; 2011; 28(6):1169-80. PubMed ID: 22179005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
